Levamisole: Might it be used in treatment and prevention of atopic diseases?

Journal of Asthma

Volumn 41, Issue 5, 2004, Pages 547-551

  Kocabas, Can Naci ^a   Sekerel, Bulent Enis ^a   Firat, Pinar Arikan ^a   Okur, Hamza ^a   Adahoglu, Gonul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Asthma; Atopy; Levamisole; Mice

Indexed keywords

ANTHELMINTIC AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOSTIMULATING AGENT; INTERLEUKIN 4; LEVAMISOLE; OVALBUMIN;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIZATION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; INTERFERON PRODUCTION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PROVOCATION TEST; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; HYPERSENSITIVITY, IMMEDIATE; LEVAMISOLE; MICE; MICE, INBRED BALB C;

EID: 4444228995     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120037655     Document Type: Article

References (19)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793.
2. Björksten B. The environment and sensitization to allergens in early childhood. Pediatr Allergy Immunol 1997; 8(10 suppl):32-39.
3. Bousquet J, Lockey RF, Malling HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53(suppl):1-42.
4. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108(2):184-190.
5. Barnes PJ. Cytokine-directed therapies for asthma. J Allergy Clin Immunol 2001; 108(2 Suppl):S72-6.
6. Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M. MAmb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002; 109(3):455-462.
7. Kimball ES, Schneider CR, Fisher MC, Clark MC. Levamisole causes differential cytokine expression by elicited mouse peritoneal macrophages. J Leukoc Biol 1992; 52:349-356.
8. Redondo JM, Lopez-Guerrero JA, Fresno M. Potentiation of interleukin-2 activity by levamisole and imidazole. Immunol Lett 1987; 14:111-116.
9. Szeto C, Gillespie KM, Mathieson PW. Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology 2000; 100:217-224.
10. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labiance R, Haller DG, Shepherd LE, Seitz JF, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345:1091-1097.
11. Holcombe RF, Milovanovic T, Stewart RM, Brodhag TM. Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints. Cancer Detect Prev 2001; 25:183-191.
12. Prakash MS, Rao VM, Reddy V. Effect of levamisole on the immune status of malnourished children. J Trop Pediatr 1998; 44:165-166.
13. Meadow SR, Sarsfield JK. Steroid-responsive nephrotic syndrome and allergy: clinical studies. Arch Dis Child 1981; 56:509-516.
14. Schulte-Wissermann H, Gortz W, Straub E. IgE in patients with glomerulonephritis and minimal change nephrotic syndrome. Eur J Pediatr 1979; 131:105-111.
15. Drachman R, Schlesinger M, Alon U, Mor J, Etzioni A, Shapira H, Ohali M, Drukker. Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome. Acta Paediatr Scand 1988; 77:721-726.
16. British Association for Pediatric Nephrology. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 1991; 337:1555-1557.
17. Dayal U, Dayal AK, Shastry JCM, Raghupaty P. Use of levamisole in maintaining remission in steroid sensitive nephrotic syndrome in children. 1994; 66:408-412.
18. Tsitoura DC, Blumenthal RL, Berry G, DeKruyff R, Umetsu DT. Mechanisms of preventing allergen induced airways hyperreactivity: role of tolerance and immune deviation. J Allergy Clin Immunol 2000; 106:239-246.
19. Yoshimoto T, Okamura H, Tagawa Y-I, Iwakura Y, Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci 1997; 94:3948-3953.